Jefferies Reiterates Buy on Dicerna Pharma (DRNA) Following 4Q - PT to $19
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Dicerna Pharma (DRNA) Tops Q4 EPS by 8c
March 10, 2016 4:10 PM ESTDicerna Pharma (NASDAQ: DRNA) reported Q4 EPS of ($0.76), $0.08 better than the analyst estimate of ($0.84).
For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.
... MoreTrading Radar for 3/10: Dollar General (DG), Canadian Solar (CSIQ), Plug Power (PLUG), Veifone (PAY) Report
March 9, 2016 2:56 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
Earnings:
BioLineRx (Nasdaq: BLRX) - consensus loss $0.06
CECO Environmental (Nasdaq: CECE) - consensus EPS $0.21
Canadian Solar (Nasdaq: CSIQ) - consensus EPS $0.76
Cantel Medical (NYSE: CMN) - consensus EPS $0.34
Cardiome Pharma (Nasdaq:... More
